Nifty

:

23250.10

Sensex

:

76295.36

-82.25 (-0.35%)
-322.08 (-0.42%)

Login

Nifty
Sensex

:
:

23250.10
76295.36

-82.25 (-0.35%)
-322.08 (-0.42%)

RPG Life Sciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 532983 | NSE: RPGLIFE

Watchlist

NSE BSE

2530.30

06-Feb-2025

Open
High
Low
Previous Close

2474.00
2559.95
2400.00
2476.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

15400
386.89
2974.95
1381.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,823.82
49.06
8

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,789.79
0.69%
9.37

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.16
9.16
9.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

31.25
16.61
8.18

PAT CAGR (%)

10 Years
5 Years
3 Years

56.42
24.75
19.41

P:E (Median)

8 Years
5 Years
3 Years

25.34
21.90
28.08

P:BV (Average)

8 Years
5 Years
3 Years

5.13
5.21
6.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.24
14.41
17.14

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 53.01
P/E Ratio 38.87
Revenue 582
EBITDA 128
Net Income 88
ROA 18.8
P/B Ratio 9.09
ROE 25.69
FCFF 26.1
FCFF Yield 0.81

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 172.71 153.70 12.37% 172.21 153.58 12.13% 165.42 147.78 11.94% 126.99 118.49 7.17%
Expenses 123.55 115.80 6.69% 126.28 116.29 8.59% 126.35 115.54 9.36% 106.27 102.58 3.60%
EBITDA 49.16 37.90 29.71% 45.93 37.29 23.17% 39.07 32.24 21.18% 20.72 15.91 30.23%
EBIDTM 28.46% 24.66% 26.67% 24.28% 23.62% 21.82% 16.32% 13.43%
Other Income 3.31 1.92 72.40% 1.94 1.83 6.01% 2.37 1.81 30.94% 1.65 1.84 -10.33%
Interest 0.12 0.14 -14.29% 0.17 0.10 70.00% 0.15 0.07 114.29% 0.14 0.05 180.00%
Depreciation 5.46 4.14 31.88% 5.31 4.23 25.53% 5.29 4.21 25.65% 4.49 3.89 15.42%
PBT 46.89 35.54 31.94% 15.09 34.79 -56.63% 36.00 29.77 20.93% 17.74 13.81 28.46%
Tax 11.96 9.08 31.72% 10.89 8.93 21.95% 9.24 7.67 20.47% 4.50 3.46 30.06%
PAT 34.93 26.46 32.01% 4.20 25.86 -83.76% 26.76 22.10 21.09% 13.24 10.35 27.92%
PATM 20.22% 17.22% 2.44% 16.84% 16.18% 14.95% 10.43% 8.73%
EPS 21.17 16.04 31.98% 2.55 15.67 -83.73% 16.22 13.39 21.14% 8.02 6.27 27.91%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 637.33 582.05 512.81 440.16 389.14 375.57 330.16 343.95 293.64 279.32 242.27 Net Sales Growth 11.12% 13.50% 16.51% 13.11% 3.61% 13.75% -4.01% 17.13% 5.13% 15.29% Cost Of Goods Sold 206.73 167.82 156.64 127.59 121.27 119.63 103.93 106.87 96.02 84.94 77.17 Gross Profit 430.60 414.23 356.17 312.57 267.87 255.94 226.23 237.08 197.62 194.38 165.10 GP Margin 67.56% 71.17% 69.45% 71.01% 68.84% 68.15% 68.52% 68.93% 67.30% 69.59% 68.15% Total Expenditure 482.45 452.91 409.28 353.00 318.37 315.67 295.73 306.89 265.01 257.02 233.76 Power & Fuel Cost - 14.36 13.65 12.69 11.27 11.54 10.38 10.44 9.10 11.23 10.76 % Of Sales - 2.47% 2.66% 2.88% 2.90% 3.07% 3.14% 3.04% 3.10% 4.02% 4.44% Employee Cost - 132.15 117.06 99.97 94.66 90.97 89.93 90.14 75.59 74.13 68.66 % Of Sales - 22.70% 22.83% 22.71% 24.33% 24.22% 27.24% 26.21% 25.74% 26.54% 28.34% Manufacturing Exp. - 43.80 36.62 37.86 28.79 21.85 18.98 21.86 20.63 26.88 23.61 % Of Sales - 7.53% 7.14% 8.60% 7.40% 5.82% 5.75% 6.36% 7.03% 9.62% 9.75% General & Admin Exp. - 41.63 37.14 33.97 28.54 32.76 34.32 35.76 31.57 24.58 21.81 % Of Sales - 7.15% 7.24% 7.72% 7.33% 8.72% 10.39% 10.40% 10.75% 8.80% 9.00% Selling & Distn. Exp. - 37.85 35.62 32.27 25.47 20.13 18.61 22.51 17.90 16.44 11.42 % Of Sales - 6.50% 6.95% 7.33% 6.55% 5.36% 5.64% 6.54% 6.10% 5.89% 4.71% Miscellaneous Exp. - 15.30 12.55 8.65 8.37 18.79 19.58 19.31 14.20 18.82 11.42 % Of Sales - 2.63% 2.45% 1.97% 2.15% 5.00% 5.93% 5.61% 4.84% 6.74% 8.39% EBITDA 154.88 129.14 103.53 87.16 70.77 59.90 34.43 37.06 28.63 22.30 8.51 EBITDA Margin 24.30% 22.19% 20.19% 19.80% 18.19% 15.95% 10.43% 10.77% 9.75% 7.98% 3.51% Other Income 9.27 7.21 4.80 3.08 1.07 0.99 0.80 2.36 9.78 1.96 6.59 Interest 0.58 1.44 1.15 1.41 1.79 2.76 4.86 4.72 3.64 2.49 2.74 Depreciation 20.55 17.07 15.50 15.66 16.47 16.36 15.32 14.34 11.31 10.15 11.36 PBT 115.72 117.84 91.68 73.17 53.58 41.77 15.05 20.36 23.46 11.62 1.00 Tax 36.59 30.18 24.04 21.69 13.58 7.44 4.24 6.91 2.45 0.00 0.00 Tax Rate 31.62% 25.61% 26.22% 29.64% 25.35% 20.41% 28.17% 33.94% 10.44% 0.00% 0.00% PAT 79.13 87.66 67.64 51.48 40.00 29.01 10.81 13.45 21.01 11.62 1.00 PAT before Minority Interest 79.13 87.66 67.64 51.48 40.00 29.01 10.81 13.45 21.01 11.62 1.00 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.42% 15.06% 13.19% 11.70% 10.28% 7.72% 3.27% 3.91% 7.16% 4.16% 0.41% PAT Growth -6.65% 29.60% 31.39% 28.70% 37.88% 168.36% -19.63% -35.98% 80.81% 1,062.00% EPS 47.96 53.13 40.99 31.20 24.24 17.58 6.55 8.15 12.73 7.04 0.61

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 374.85 307.60 255.77 216.45 176.57 160.50 154.75 147.01 133.59 125.16 Share Capital 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 Total Reserves 361.62 294.37 242.54 203.22 163.34 147.27 141.52 133.78 120.36 111.93 Non-Current Liabilities 6.48 8.97 8.73 7.19 8.75 9.58 8.37 10.77 22.45 19.93 Secured Loans 0.00 0.00 0.01 0.08 0.22 4.63 10.11 15.89 0.13 0.17 Unsecured Loans 0.00 0.00 0.29 0.66 1.30 1.95 0.12 0.16 0.11 0.15 Long Term Provisions 4.03 3.98 3.04 3.13 8.50 6.19 2.79 2.32 19.60 16.95 Current Liabilities 130.96 102.78 80.11 79.69 82.59 77.82 120.71 78.68 66.80 67.19 Trade Payables 71.02 64.69 45.50 47.44 44.41 25.13 51.87 28.65 33.71 25.30 Other Current Liabilities 45.05 26.23 19.87 18.12 20.30 13.32 18.47 14.91 10.17 6.64 Short Term Borrowings 0.00 0.00 0.21 0.52 5.12 29.04 37.92 24.01 21.96 32.46 Short Term Provisions 14.89 11.86 14.53 13.61 12.76 10.33 12.45 11.11 0.96 2.79 Total Liabilities 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46 222.84 212.28 Net Block 113.53 124.26 103.71 113.30 122.89 127.64 130.80 136.67 109.26 104.52 Gross Block 221.52 220.01 186.37 180.44 173.81 162.55 150.65 142.43 189.83 175.51 Accumulated Depreciation 107.99 95.75 82.66 67.14 50.92 34.91 19.85 5.76 80.57 70.99 Non Current Assets 214.20 155.30 137.70 127.48 142.13 150.81 141.21 140.08 135.65 126.18 Capital Work in Progress 96.31 25.44 31.06 11.77 9.98 17.17 8.73 1.82 1.59 0.72 Non Current Investment 1.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 3.35 5.60 2.93 2.41 9.26 6.00 1.68 1.59 24.80 20.94 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 298.09 264.05 206.91 175.85 125.78 97.09 142.62 96.38 87.19 86.10 Current Investments 90.15 58.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 101.00 95.05 82.99 58.33 46.61 41.04 53.69 45.78 39.02 34.48 Sundry Debtors 49.13 37.43 32.99 57.42 63.33 38.90 68.13 39.28 36.99 40.61 Cash & Bank 36.47 57.04 70.26 40.75 1.11 0.77 0.94 1.60 0.80 0.72 Other Current Assets 21.34 5.41 6.64 8.71 14.73 16.38 19.86 9.72 10.38 10.29 Short Term Loans & Adv. 16.48 10.69 14.03 10.64 6.51 9.45 12.26 4.13 9.80 10.29 Net Current Assets 167.13 161.27 126.80 96.16 43.19 19.27 21.91 17.70 20.39 18.91 Total Assets 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46 222.84 212.28

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 94.36 90.82 64.75 58.27 50.17 45.78 14.68 7.33 32.81 -1.97 PBT 117.84 91.68 73.17 53.58 36.45 15.05 20.36 23.46 11.62 1.00 Adjustment 12.92 13.31 13.54 16.55 22.52 20.08 17.37 6.95 12.64 7.39 Changes in Working Capital -7.09 11.06 -3.11 -3.53 -2.37 14.37 -19.35 -18.81 10.92 -6.47 Cash after chg. in Working capital 123.67 116.05 83.60 66.60 56.60 49.50 18.38 11.60 35.18 1.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -29.31 -25.23 -18.85 -8.33 -6.43 -3.72 -3.70 -4.27 -2.37 -3.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -79.15 -105.81 -34.66 -7.96 -10.70 -19.02 -15.54 -30.06 -15.25 -10.31 Net Fixed Assets -72.38 -28.02 -25.22 -8.42 -4.07 -20.34 -15.13 47.17 -15.19 -8.46 Net Investments -32.73 -58.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 25.96 -19.36 -9.44 0.46 -6.63 1.32 -0.41 -77.23 -0.06 -1.85 Cash from Financing Activity -20.31 -17.12 -13.51 -10.49 -39.30 -26.50 0.11 23.36 -17.58 12.24 Net Cash Inflow / Outflow -5.10 -32.11 16.58 39.82 0.17 0.26 -0.75 0.63 -0.02 -0.04 Opening Cash & Equivalents 24.82 56.93 40.36 0.54 0.37 0.11 0.86 0.23 0.25 0.29 Closing Cash & Equivalent 19.72 24.82 56.94 40.36 0.54 0.37 0.11 0.86 0.23 0.25

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 226.67 186.00 154.66 130.88 106.77 97.05 93.58 88.89 80.78 75.68 ROA 18.82% 17.71% 15.89% 14.00% 11.25% 4.07% 5.17% 9.15% 5.34% 0.47% ROE 25.69% 24.01% 21.80% 20.36% 17.21% 6.86% 8.91% 14.98% 8.98% 0.80% ROCE 34.96% 32.92% 31.46% 27.27% 20.35% 9.81% 12.52% 15.58% 8.97% 2.50% Fixed Asset Turnover 2.83 2.73 2.61 2.37 2.23 2.11 2.37 1.85 1.59 1.47 Receivable days 25.32 23.17 34.41 52.52 49.68 59.16 56.47 45.37 48.80 55.80 Inventory Days 57.35 58.57 53.79 45.64 42.59 52.36 52.29 50.44 46.22 52.39 Payable days 147.58 128.38 132.94 138.23 44.01 56.38 53.51 47.24 47.03 55.90 Cash Conversion Cycle -64.92 -46.65 -44.74 -40.07 48.25 55.15 55.25 48.57 47.99 52.29 Total Debt/Equity 0.00 0.00 0.00 0.01 0.07 0.23 0.35 0.30 0.17 0.27 Interest Cover 82.83 80.72 52.89 30.93 14.21 4.10 5.31 7.45 5.67 1.36

Top Investors:

authum investment and infrastructure limited

quant mutual fund - quant active fund

mirae asset multicap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

RPG Life Sciences - Quarterly Results
24th Jan 2025, 19:26 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback